AstraZeneca arthritis pill performs poorly in new study
LONDON (Reuters) - AstraZeneca's experimental rheumatoid arthritis pill fostamatinib met only one of two goals in a late-stage clinical trial, leaving...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/SnonHcO0sZk/story01.htm
No comments:
Post a Comment